Nanotechnology-enabled drug delivery is opening prospective future in pharmaceutics. The emergence of nanotechnology is likely to have a significant impact on drug delivery sector, affecting just about every route of administration from oral to injectable.
The present pharmaceutic is often characterized by poor bio-availability which far too often results in higher patient costs and inefficient treatment but also, more importantly, increased risks of toxicity or even death.
Nanotechnology focuses on the very small and it is uniquely suited to creating systems that can better deliver drugs to tiny areas within the body.
Nano-enabled drug delivery also makes it possible for drugs to permeate through cell walls, which is of critical importance to the expected growth of genetic medicine over the next few years.
The researches indicate that nano- enabled solutions in drug delivery will capture a small but rapidly growing percentage of this total market based on their ability to reduce times to market, extend product life cycles, provide patent protection and create additional revenue streams.
The payoff for doctors and patients from nanotechnology-enabled drug delivery should be lower drug toxicity, reduced cost of treatments, improved bioavailability and an extension of the economic life of proprietary drugs.
высшее образование 
© 2005-2012 Украинский хостинг - лучший платный хостинг. При использовании материалов ссылка наука.харьков.украина обязательна.
